Chester County News and Community Website
Recro (Nasdaq: REPH), headquartered in Malvern, PA, is a contract development and manufacturing organization, or CDMO, with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products. For more information see www.recrocdmo.com.
EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced the recent expansion of its team through the addition of new employees to support product development, business development, quality, technical operations, …
Recro Reports Inducement Grants for New Staff Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced this week’s signing of a renewable energy agreement with Georgia Power under which the company will purchase 1.2 million renewable energy …
Recro Signs Renewable Energy Agreement with Georgia Power Read More EXTON, PA — Recro Pharma, Inc. (“Recro”; NASDAQ: REPH) recently announced its acquisition of IRISYS, a San Diego-based CDMO that possesses capabilities that complement and expand those of Recro.
Recro Announces Acquisition of San Diego-based IRISYS Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) this week announced that it has signed a non-binding letter of intent for its acquisition of a full-service CDMO with capabilities that …
Recro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMO Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) recently reported financial results for the second quarter and six months ended June 30, 2021.
Recro Reports Second Quarter 2021 Financial Results Read More EXTON, PA — Recro Pharma, Inc. (: REPH) announced that the company will release financial results for the second quarter 2021 after the market close on Monday, August 9, 2021. …
Recro To Report Financial Results for Second Quarter 2021 Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced the appointment of Erica Raether as the company’s inaugural vice president of people, culture and ESG (environmental, social and governance). Ms. …
Recro Appoints Erica Raether as Vice President of People, Culture and ESG Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced the expansion of its team through the addition of new employees to support business development, technical operations and certain strategic initiatives.
Recro Reports Inducement Grants for New Staff Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Recro Appoints Laura L. Parks, Ph.D. to Board of Directors Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH), a dedicated contract development and manufacturing organization (CDMO) solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, …
Recro Reports First Quarter 2021 Financial Results Read More